Susanne M. Arnold

7.1k total citations
166 papers, 2.8k citations indexed

About

Susanne M. Arnold is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Susanne M. Arnold has authored 166 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Oncology, 55 papers in Pulmonary and Respiratory Medicine and 44 papers in Molecular Biology. Recurrent topics in Susanne M. Arnold's work include Lung Cancer Research Studies (36 papers), Head and Neck Cancer Studies (26 papers) and Lung Cancer Treatments and Mutations (25 papers). Susanne M. Arnold is often cited by papers focused on Lung Cancer Research Studies (36 papers), Head and Neck Cancer Studies (26 papers) and Lung Cancer Treatments and Mutations (25 papers). Susanne M. Arnold collaborates with scholars based in United States, Germany and Spain. Susanne M. Arnold's co-authors include Roy A. Patchell, Kenneth L. Kirsh, Steven D. Passik, Kristi D. Graves, Mohammed Mohiuddin, Joseph Valentino, William F. Regine, Lowell Anthony, Aman Chauhan and Paul M. Spring and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Susanne M. Arnold

156 papers receiving 2.7k citations

Peers

Countries citing papers authored by Susanne M. Arnold

Since Specialization

Citations

This map shows the geographic impact of Susanne M. Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanne M. Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanne M. Arnold more than expected).

Fields of papers citing papers by Susanne M. Arnold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanne M. Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanne M. Arnold. The network helps show where Susanne M. Arnold may publish in the future.

Co-authorship network of co-authors of Susanne M. Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of Susanne M. Arnold. A scholar is included among the top collaborators of Susanne M. Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanne M. Arnold. Susanne M. Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-life per- and polyfluoroalkyl substances mixture impairs placental function: insights from a trophoblast spheroid model 2025 ·Environmental Research ·(unknown), Qiuguo Fu, (unknown), Stefan Fest, Susanne M. Arnold, Mario Bauer, (unknown), Ana Claudia Zenclussen, Violeta Stojanovska	0
2	Cancer research provides a model for advancing clinical trials in dementia in the era of disease-modifying Alzheimer’s-type dementia therapies 2024 ·Alzheimer s Research & Therapy ·Gregory A. Jicha, T. C. Tucker, Susanne M. Arnold, Peter T. Nelson	2
3	A Probabilistic Approach to Estimate the Temporal Order of Pathway Mutations Accounting for Intra-Tumor Heterogeneity 2024 ·Cancers ·(unknown), Yanqi Xie, Jinpeng Liu, (unknown), Li Chen, Arnold J. Stromberg, Susanne M. Arnold, Chunming Liu, Chi Wang	2
4	Perspectives of facilitators and barriers to cancer clinical trial participation: A mixed-methods study. 2024 ·Journal of Clinical Oncology ·Lovoria B. Williams, Jessica L. Burris, (unknown), (unknown), (unknown), Susanne M. Arnold	2
5	Abstract CT249: Results from KEYMAKER-U01 substudy 3: a phase 2 umbrella study of pembrolizumab plus investigational agents in patients with non-small-cell lung cancer (NSCLC) previously treated with anti-PD-(L)1 therapy 2024 ·Cancer Research ·Charu Aggarwal, James Stevenson, Dariusz M. Kowalski, Tibor Csőszi, Nir Peled, Byoung Chul Cho, Belén Rubio‐Viqueira, Jiaxin Niu, David P. Carbone, Susanne M. Arnold, Mark M. Awad, Justin F. Gainor, Suman Rao, Anne S. Tsao, Heng Zhou, (unknown), Elliot Chartash, Ernest Nadal	1
6	A phase II randomized control trial of triapine plus lutetium 177 DOTATATE versus lutetium 177 DOTATATE alone for well-differentiated somatostatin receptor-positive neuroendocrine tumors. 2024 ·Journal of Clinical Oncology ·Aman Chauhan, Charles A. Kunos, Susanne M. Arnold, Heidi L. Weiss, S. Percy Ivy, Steven D. Gore, Larry Rubinstein, Lorraine Pelosof, Jan H. Beumer, Jill Kolesar, William E. Carson, Elise C. Kohn, Lowell Anthony	0
7	Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study 2024 ·JCO Precision Oncology ·(unknown), Shulin Zhang, Nan Lin, (unknown), E Belcher, (unknown), Thèrése Bocklage, Rachel W. Miller, John L. Villano, Michael J. Cavnar, Joseph Kim, Susanne M. Arnold, Frederick R. Ueland, Jill Kolesar	1
8	Association of first primary cancer with risk of subsequent primary cancer among survivors of adult-onset cancers in Kentucky and Appalachian Kentucky 2023 ·Frontiers in Oncology ·Quan Chen, Bin Huang, Abigail Anderson, Eric B. Durbin, Susanne M. Arnold, Jill Kolesar	3
9	The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors 2023 ·Cancers ·(unknown), (unknown), James L. Chen, Aakrosh Ratan, Martin D. McCarter, John D. Carpten, Howard Colman, Alexandra P. Ikeguchi, Igor Puzanov, Susanne M. Arnold, Michelle L. Churchman, Patrick Hwu, José R. Conejo-García, William S. Dalton, George J. Weiner, Issam El Naqa, Ahmad A. Tarhini	5
10	A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer 2023 ·Cancers ·Zin Myint, William H. St. Clair, Stephen E. Strup, Donglin Yan, (unknown), Derek B. Allison, Laurie E. McLouth, (unknown), Peng Wang, Andrew James, Patrick J. Hensley, D. Otto, Susanne M. Arnold, Robert S. DiPaola, Jill Kolesar	6
11	Incorporating long non-coding RNA (lncRNA) into genome-wide biomarker screening for prognostic gene signatures of immunotherapy outcomes. 2023 ·Journal of Clinical Oncology ·Xuefeng Wang, (unknown), Vineeth Sukrithan, Aakrosh Ratan, Martin D. McCarter, John D. Carpten, Howard Colman, Alexandra P. Ikeguchi, Igor Puzanov, Susanne M. Arnold, Michelle L. Churchman, Patrick Hwu, William S. Dalton, George J. Weiner, Ahmad A. Tarhini	2
12	Molecular Tumor Board–Assisted Care in an Advanced Cancer Population: Results of a Phase II Clinical Trial 2022 ·JCO Precision Oncology ·Rachel W. Miller, (unknown), Heidi L. Weiss, Jianrong Wu, Chi Wang, Jinpeng Liu, Rani Jayswal, (unknown), Abigail Anderson, Derek B. Allison, Riham El Khouli, Reema Patel, John L. Villano, Susanne M. Arnold, Jill Kolesar	21
13	Characterization of Three-Dimensional Trophoblast Spheroids: An Alternative Model to Study the Physiological Properties of the Placental Unit 2022 ·Cells ·Violeta Stojanovska, Susanne M. Arnold, Mario Bauer, (unknown), Stefan Fest, Ana Claudia Zenclussen	21
14	Clinical Outcomes of Molecular Tumor Boards: A Systematic Review 2021 ·JCO Precision Oncology ·Kara Larson, Bin Huang, Heidi L. Weiss, Pamela C. Hull, Philip M. Westgate, Rachel W. Miller, Susanne M. Arnold, Jill Kolesar	52
15	Molecular Tumor Board Review and Improved Overall Survival in Non–Small-Cell Lung Cancer 2021 ·JCO Precision Oncology ·Bin Huang, Quan Chen, Derek B. Allison, Riham El Khouli, (unknown), James A. Mobley, Abigail Anderson, Eric B. Durbin, (unknown), John L. Villano, Rachel W. Miller, Susanne M. Arnold, Jill Kolesar	18
16	EGFR testing and erlotinib use in non-small cell lung cancer patients in Kentucky 2020 ·PLoS ONE ·Kara Larson, Bin Huang, Quan Chen, (unknown), (unknown), Susanne M. Arnold, Jill Kolesar	9
17	A case-control study of trace-element status and lung cancer in Appalachian Kentucky 2019 ·PLoS ONE ·Jason M. Unrine, Stacey Slone, Wayne T. Sanderson, Nancy E. Johnson, Eric B. Durbin, (unknown), Ellen J. Hahn, (unknown), Bin Huang, W. Jay Christian, Isabel Mellon, David K. Orren, Susanne M. Arnold	19
18	Low-Dose Fractionated Radiation Potentiates the Effects of Cisplatin Independent of the Hyper-Radiation Sensitivity in Human Lung Cancer Cells 2011 ·Molecular Cancer Therapeutics ·Seema Gupta, Tulay Koru‐Sengul, Susanne M. Arnold, Gayathri R. Devi, Mohammed Mohiuddin, Mansoor M. Ahmed	52
19	A Phase I Study of 7- t -Butyldimethylsilyl-10-Hydroxycamptothecin in Adult Patients with Refractory or Metastatic Solid Malignancies 2010 ·Clinical Cancer Research ·Susanne M. Arnold, John J. Rinehart, Eleftheria Tsakalozou, John R. Eckardt, Scott Z. Fields, Brent J. Shelton, Philip A. DeSimone, Bryan K. Kee, Jeffrey A. Moscow, Markos Leggas	23
20	Gender differences in psychosocial responses to lung cancer 2010 ·Gender Medicine ·Joy M. Jacobs‐Lawson, (unknown), Travonia Hughes, Susanne M. Arnold	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact